Mutation burden and other molecular markers of prognosis in colorectal cancer treated with curative intent: results from the QUASAR 2 clinical trial and an Australian community-based series

Domingo, E; Camps, C; Kaisaki, PJ; Parsons, MJ; Mouradov, D; Pentony, MM; Makino, S; ... Tomlinson, I; + view all Domingo, E; Camps, C; Kaisaki, PJ; Parsons, MJ; Mouradov, D; Pentony, MM; Makino, S; Palmieri, M; Ward, RL; Hawkins, NJ; Gibbs, P; Askautrud, H; Oukrif, D; Wang, H; Wood, J; Tomlinson, E; Bark, Y; Kaur, K; Johnstone, EC; Palles, C; Church, DN; Novelli, M; Danielsen, HE; Sherlock, J; Kerr, D; Kerr, R; Sieber, O; Taylor, JC; Tomlinson, I; - view fewer (2018) Mutation burden and other molecular markers of prognosis in colorectal cancer treated with curative intent: results from the QUASAR 2 clinical trial and an Australian community-based series. The Lancet Gastroenterology and Hepatology 10.1016/S2468-1253(18)30117-1 . (In press). Green open access

https://ift.tt/2A1zb9O